Tumor suppressor gene PDCD4 negatively regulates autophagy by inhibiting the expression of autophagy-related gene ATG5

Autophagy

Volumn 9, Issue 5, 2013, Pages 743-755

  Song, Xingguo ^a   Zhang, Xia ^b   Wang, Xiaoyan ^a   Zhu, Faliang ^a   Guo, Chun ^a   Wang, Qun ^a   Shi, Yongyu ^a   Wang, Jianing ^a   Chen, Youhai ^c   Zhang, Lining ^a  

^a SHANDONG UNIVERSITY   (China)

^b YANTAI YUHUANGDING HOSPITAL   (China)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Atg5; Autophagy; PDCD4; Proliferation; Tumor Suppressor

Indexed keywords

AUTOPHAGY PROTEIN 12; AUTOPHAGY PROTEIN 5; MEMBRANE RECEPTOR; PROGRAMMED CELL DEATH PROTEIN 4; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CANCER INHIBITION; CELL TYPE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; REGULATORY MECHANISM; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT;

EID: 84877356169     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.24069     Document Type: Article

References (51)

1. Lankat-Buttgereit B, Göke R. The tumour suppressor Pdcd4: Recent advances in the elucidation of function and regulation. Biol Cell 2009; 101:309-17; PMID:19356152; http://dx.doi.org/10.1042/BC20080191
2. Göke A, Göke R, Knolle A, Trusheim H, Schmidt H, Wilmen A, et al. DUG is a novel homologue of translation initiation factor 4G that binds eIF4A. Biochem Biophys Res Commun 2002; 297:78-82; PMID:12220511; http://dx.doi.org/10.1016/S0006-291X(02)02129-0
3. Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S, et al. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 2003; 23:26-37; PMID:12482958; http://dx.doi.org/10.1128/MCB.23.1.26-37.2003
4. Yang HS, Cho MH, Zakowicz H, Hegamyer G, Sonenberg N, Colburn NH. A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol Cell Biol 2004; 24:3894-906; PMID:15082783; http://dx.doi.org/10.1128/MCB. 24.9.3894-3906.2004
5. Singh P, Wedeken L, Waters LC, Carr MD, Klempnauer KH. Pdcd4 directly binds the coding region of c-myb mRNA and suppresses its translation. Oncogene 2011; 30:4864-73; PMID:21643008; http://dx.doi.org/10.1038/onc.2011.202
6. Yang HS, Knies JL, Stark C, Colburn NH. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene 2003; 22:3712-20; PMID:12802278; http://dx.doi.org/10.1038/sj.onc.1206433
7. Yang HS, Matthews CP, Clair T, Wang Q, Baker AR, Li CC, et al. Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol 2006; 26:1297-306; PMID:16449643; http://dx.doi.org/10.1128/MCB.26.4. 1297-1306.2006
8. Jansen AP, Camalier CE, Colburn NH. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res 2005; 65:6034-41; PMID:16024603; http://dx.doi.org/10.1158/0008-5472.CAN-04- 2119
9. Hilliard A, Hilliard B, Zheng SJ, Sun H, Miwa T, Song W, et al. Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4. J Immunol 2006; 177:8095-102; PMID:17114484
10. Chen Y, Knösel T, Kristiansen G, Pietas A, Garber ME, Matsuhashi S, et al. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J Pathol 2003; 200:640-6; PMID:12898601; http://dx.doi.org/10.1002/path.1378
11. Zhang Z, DuBois RN. Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor. Oncogene 2001; 20:4450-6; PMID:11494140; http://dx.doi.org/10.1038/sj.onc.1204588
12. Gao F, Zhang P, Zhou C, Li J, Wang Q, Zhu F, et al. Frequent loss of PDCD4 expression in human glioma: Possible role in the tumorigenesis of glioma. Oncol Rep 2007; 17:123-8; PMID:17143488
13. Wang X, Wei Z, Gao F, Zhang X, Zhou C, Zhu F, et al. Expression and prognostic significance of PDCD4 in human epithelial ovarian carcinoma. Anticancer Res 2008; 28(5B):2991-6; PMID:19031945
14. Zhang H, Ozaki I, Mizuta T, Hamajima H, Yasutake T, Eguchi Y, et al. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Oncogene 2006; 25:6101-12; PMID:16682950; http://dx.doi.org/10.1038/sj.onc.1209634
15. Wei ZT, Zhang X, Wang XY, Gao F, Zhou CJ, Zhu FL, et al. PDCD4 inhibits the malignant phenotype of ovarian cancer cells. Cancer Sci 2009; 100:1408-13; PMID:19493270; http://dx.doi.org/10.1111/j.1349-7006.2009.01210.x
16. Zhang X, Wang X, Song X, Liu C, Shi Y, Wang Y, et al. Programmed cell death 4 enhances chemosensitivity of ovarian cancer cells by activating death receptor pathway in vitro and in vivo. Cancer Sci 2010; 101:2163-70; PMID:20735432; http://dx.doi.org/10.1111/j.1349-7006.2010.01664.x
17. Shibahara K, Asano M, Ishida Y, Aoki T, Koike T, Honjo T. Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene 1995; 166:297-301; PMID:8543179; http://dx.doi.org/10.1016/0378-1119(95)00607-9
18. Gao F, Wang X, Zhu F, Wang Q, Zhang X, Guo C, et al. PDCD4 gene silencing in gliomas is associated with 5'CpG island methylation and unfavourable prognosis. J Cell Mol Med 2009; 13:4257-67; PMID:18793349; http://dx.doi.org/10. 1111/j.1582-4934.2008.00497.x
19. Afonja O, Juste D, Das S, Matsuhashi S, Samuels HH. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene 2004; 23:8135-45; PMID:15361828; http://dx.doi.org/10.1038/sj.onc.1207983
20. Wang WQ, Zhang H, Wang HB, Sun YG, Peng ZH, Zhou G, et al. Programmed cell death 4 (PDCD4) enhances the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by inhibiting the PI3K/Akt signaling pathway. Mol Diagn Ther 2010; 14:155-61; PMID:20560677; http://dx.doi.org/10.1007/BF03256368
21. Eto K, Goto S, Nakashima W, Ura Y, Abe SI. Loss of programmed cell death 4 induces apoptosis by promoting the translation of procaspase-3 mRNA. Cell Death Differ 2012; 19:573-81; PMID:21959934; http://dx.doi.org/10.1038/cdd.2011. 126
22. Göke R, Barth P, Schmidt A, Samans B, Lankat-Buttgereit B. Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). Am J Physiol Cell Physiol 2004; 287:C1541-6; PMID:15317660; http://dx.doi.org/10.1152/ajpcell. 00025.2004
23. Lankat-Buttgereit B, Lenschen B, Schmidt H, Göke R. The action of Pdcd4 may be cell type specific: Evidence that reduction of dUTPase levels might contribute to its tumor suppressor activity in Bon-1 cells. Apoptosis 2008; 13:157-64; PMID:17955371; http://dx.doi.org/10.1007/s10495-007-0153-x
24. Choi KS. Autophagy and cancer. Exp Mol Med 2012; 44:109-20; PMID:22257886; http://dx.doi.org/10.3858/emm.2012.44.2.033
25. Czyzyk-Krzeska MF, Meller J, Plas DR. Not all autophagy is equal. Autophagy 2012; 8:1155-6; PMID:22647376; http://dx.doi.org/10.4161/auto.20650
26. Ogier-Denis E, Codogno P. Autophagy: A barrier or an adaptive response to cancer. Biochim Biophys Acta 2003; 1603:113-28; PMID:12618311
27. Lin CI, Whang EE, Abramson MA, Jiang X, Price BD, Donner DB, et al. Autophagy: A new target for advanced papillary thyroid cancer therapy. Surgery 2009; 146:1208-14; PMID:19958950; http://dx.doi.org/10.1016/j.surg.2009.09.019
28. Yamaki M, Umehara T, Chimura T, Horikoshi M. Cell death with predominant apoptotic features in Saccharomyces cerevisiae mediated by deletion of the histone chaperone ASF1/CIA1. Genes Cells 2001; 6:1043-54; PMID:11737265; http://dx.doi.org/10.1046/j.1365-2443.2001.00487.x
29. Arico S, Petiot A, Bauvy C, Dubbelhuis PF, Meijer AJ, Codogno P, et al. The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway. J Biol Chem 2001; 276:35243-6; PMID:11477064; http://dx.doi.org/10.1074/jbc.C100319200
30. Inbal B, Bialik S, Sabanay I, Shani G, Kimchi A. DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death. J Cell Biol 2002; 157:455-68; PMID:11980920; http://dx.doi.org/10.1083/jcb.200109094
31. Kvam E, Gable K, Dunn TM, Goldfarb DS. Targeting of Tsc13p to nucleus-vacuole junctions: A role for very-long-chain fatty acids in the biogenesis of microautophagic vesicles. Mol Biol Cell 2005; 16:3987-98; PMID:15958487; http://dx.doi.org/10.1091/mbc.E05-04-0290
32. Hanada T, Noda NN, Satomi Y, Ichimura Y, Fujioka Y, Takao T, et al. The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in autophagy. J Biol Chem 2007; 282:37298-302; PMID:17986448; http://dx.doi.org/10. 1074/jbc.C700195200
33. Fujita N, Itoh T, Omori H, Fukuda M, Noda T, Yoshimori T. The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy. Mol Biol Cell 2008; 19:2092-100; PMID:18321988; http://dx.doi.org/10. 1091/mbc.E07-12-1257
34. Tassa A, Roux MP, Attaix D, Bechet DM. Class III phosphoinositide 3-kinase-Beclin1 complex mediates the amino acid-dependent regulation of autophagy in C2C12 myotubes. Biochem J 2003; 376:577-86; PMID:12967324; http://dx.doi.org/10.1042/BJ20030826
35. Juhász G, Hill JH, Yan Y, Sass M, Baehrecke EH, Backer JM, et al. The class III PI(3)K Vps34 promotes autophagy and endocytosis but not TOR signaling in Drosophila. J Cell Biol 2008; 181:655-66; PMID:18474623; http://dx.doi.org/10.1083/jcb.200712051
36. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008; 4:151-75; PMID:18188003
37. Vikhreva PN, Shepelev MV, Korobko EV, Korobko IV. Pdcd4 tumor suppressor: Properties, functions, and their application to oncology. Mol Gen Mikrobiol Virusol 2010; 2:3-11; PMID:20545042
38. Wedeken L, Singh P, Klempnauer KH. Tumor suppressor protein Pdcd4 inhibits translation of p53 mRNA. J Biol Chem 2011; 286:42855-62; PMID:22033922; http://dx.doi.org/10.1074/jbc.M111.269456
39. Mizushima N, Sugita H, Yoshimori T, Ohsumi Y. A new protein conjugation system in human. The counterpart of the yeast Apg12p conjugation system essential for autophagy. J Biol Chem 1998; 273:33889-92; PMID:9852036; http://dx.doi.org/10.1074/jbc.273.51.33889
40. Scherz-Shouval R, Weidberg H, Gonen C, Wilder S, Elazar Z, Oren M. p53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation. Proc Natl Acad Sci U S A 2010; 107:18511-6; PMID:20937856; http://dx.doi.org/10.1073/pnas.1006124107
41. Stevens C, Lin Y, Harrison B, Burch L, Ridgway RA, Sansom O, et al. Peptide combinatorial libraries identify TSC2 as a death-associated protein kinase (DAPK) death domain-binding protein and reveal a stimulatory role for DAPK in mTORC1 signaling. J Biol Chem 2009; 284:334-44; PMID:18974095; http://dx.doi.org/10.1074/jbc.M805165200
42. Sherr CJ. Autophagy by ARF: A short story. [Review]. Mol Cell 2006; 22:436-7; PMID:16713573; http://dx.doi.org/10.1016/j.molcel.2006.05.005
43. Takahashi Y, Coppola D, Matsushita N, Cualing HD, Sun M, Sato Y, et al. Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat Cell Biol 2007; 9:1142-51; PMID:17891140; http://dx.doi.org/10.1038/ncb1634
44. Moscat J, Diaz-Meco MT. p62: A versatile multitasker takes on cancer. Trends Biochem Sci 2012; 37:230-6; PMID:22424619; http://dx.doi.org/10.1016/j. tibs.2012.02.008
45. Qu X, Zou Z, Sun Q, Luby-Phelps K, Cheng P, Hogan RN, et al. Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell 2007; 128:931-46; PMID:17350577; http://dx.doi.org/10.1016/j.cell.2006.12.044
46. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005; 122:927-39; PMID:16179260; http://dx.doi.org/10.1016/j.cell.2005.07.002
47. Yousefi S, Perozzo R, Schmid I, Ziemiecki A, Schaffner T, Scapozza L, et al. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol 2006; 8:1124-32; PMID:16998475; http://dx.doi.org/10.1038/ncb1482
48. Hoppe-Seyler F, Butz K. Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53. J Virol 1993; 67:3111-7; PMID:8388491
49. Van Meir EG, Kikuchi T, Tada M, Li H, Diserens AC, Wojcik BE, et al. Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res 1994; 54:649-52; PMID:8306326
50. Khaoustov VI, Ozer A, Smith JR, Noda A, Mearns M, Krishnan B, et al. Induction of senescent cell-derived inhibitor of DNA synthesis gene, SDI1, in hepatoblastoma (HepG2) cells arrested in the G2-phase of the cell cycle by 9-nitrocamptothecin. Lab Invest 1995; 73:118-27; PMID:7603034
51. Vikhanskaya F, Erba E, D'Incalci M, Broggini M. Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogenous p53. Nucleic Acids Res 1994; 22:1012-7; PMID:8152906; http://dx.doi.org/10.1093/nar/22.6.1012